The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

Weblogs

MIM 2018: Submission deadline extended for abstract, symposia, workshops, pre-conference and exhibition until 31st October, 2017

September 29, 2017 - 08:30 -- MIM 2018

On behalf of the 7th MIM local organizing committee, the MIM Secretariat and the Conference Scientific committee, we are pleased to announce that the abstract, symposium and exhibition submission deadline has been extended to October 31st, 2017 in response to numerous requests and due to the increased interest in the upcoming 7th MIM conference.

MIM 2018 - One of our keynote speaker: Prof. Peter Agre

September 29, 2017 - 08:20 -- MIM 2018

A word from one of our keynote speakers at the MIM2018 , Prof. Peter Agre : 2003 Nobel prize recipient in Chemistry. “My sense tells me that this would be an opportunity to meet many young scientists, that I’ve never met previously, and who are doing important work, particularly work relevant to the problems in Africa.”

MIM 2018 - One of our keynote speaker: Dr Thomas Kariuki

September 22, 2017 - 05:49 -- MIM 2018

A word from one of our keynote speakers at the MIM2018, Dr. Thomas Kariuki : Director of Alliance for accelerating Excellence in Science in Africa (AESA) & African Academy of Sciences (AAS). “Congratulations to the University Cheikh Anta Diop (UCAD) for being chosen to host the MIM conference, that’s excellent news for Senegal, and I’m looking forward to participating in the meeting.”

MIM2018: Word from the Local Organizing Committee Chair Prof Oumar Gaye

September 8, 2017 - 09:34 -- MIM 2018


Twenty years after the first MIM Conference which drew attention to major questions for malaria research, and identify ways to strengthen and sustain the research capacity of malaria endemic countries in Africa, several countries in Africa are now engaging towards malaria elimination. Focus in Senegal, the first country report in the Roll Back Malaria Progress & Impact series describes how Senegal achieves a spectacular drop in its malaria burden.

MIM2018: Submit your abstract for the 7th MIM Pan-African Malaria Conference

September 1, 2017 - 07:55 -- MIM 2018

All abstracts must be submitted by September 30, 2017.
The Secretariat offers technical assistance for abstract submissions from now until the submission date. Contact the MIM Secretariat at info@mim2018.com or (+221) 33 825 19 99

Submit your abstract by clicking here.

How malariaworld.org saves lives!

July 28, 2017 - 20:14 -- Irene Teis

Thank you MP for your blog http://mosquitopundit.net/mosquitopundit-blog/act-and-malaria-recrudesce....

You give me a lot of credit when you state: malaria researcher Irene Teis doesn’t know that her 2 April 2016 post “Was the Nobel prize for artemisinin a fatal error” at www.malariaworld.org helped save at least nine lives.

Malaria Elimination: Significance of Plasmodium vivax in Bone Marrow/Spleen

June 30, 2017 - 13:18 -- Miles Markus

The occurrence of Plasmodium vivax in bone marrow/spleen has been reported by various authors (including Baro, del Portillo, Lacerda, Marti, Obaldia, Siqueira and Wirth). It is not apparent from the title, but some of the implications hereof are discussed in the 2017 article on “Malaria Eradication and the Hidden Parasite Reservoir” (click here).

Plasmodium vivax Recurrences

June 9, 2017 - 00:16 -- Miles Markus

A new blood-stage parasite question has arisen. Are erythrocytic forms in bone marrow/spleen part of the hidden Plasmodium vivax reservoir? Do they cause or contribute to renewed or increased peripheral parasitaemia? (Link to the article on the subject [click here]).

Superbug: an emerging and quickly spreading threat to the race against malaria

February 17, 2017 - 09:46 -- Salomé Beaujouan

While the malaria death count in Cambodia dropped to just one case in 2016, a new threat to the race against the disease arises in south-eastern Asia: superbugs. A superbug is a drug-resistant, human-killing parasite that modern medicine struggles to combat.

Gene deletion P.falciparum mutants pose challenge to widely used diagnostic tests and eradication efforts

December 6, 2016 - 21:36 -- David Tordrup

In a current paper in the Journal of Infectious Diseases, recently reviewed at Global Health Technology Review, Dr. Jonathan Parr (University of North Carolina) examines cases of RDT-negative P.falciparum cases as part of the Demographic Health Survey of Democratic Republic of the Congo.

History and Hypnozoites

December 5, 2016 - 23:00 -- Miles Markus

What has happened to various hypnozoite-associated (in one way or another) personalities from the late 1970s and the 1980s, when the malarial hypnozoite was "accidentally" discovered, is not widely known. People occasionally enquire about these individuals. Some, such as M.R. Hollingdale, R.E. Sinden, G.A.T. Targett and M.B.

Your participation and support requested for promoting south-centred collaborations in vector-borne diseases

October 11, 2016 - 15:12 -- Gerry Killeen

Dear Colleagues

I have just posted the attached concept note entitled "Promoting south-centred collaborations in vector-borne diseases" on the extranet discussion board for the following UK-BBSRC funding mechanism to support networks in vector-borne disease (VBD) research:

http://www.bbsrc.ac.uk/funding/filter/networks-vector-borne-disease-research/

Vivax and Non-vivax Malaria: Elimination-related Research Agenda Items

September 3, 2016 - 22:59 -- Miles Markus

The presumed hypnozoite reservoir is perceived to be a threat to the goal of eradicating human malaria. However, the same now applies to putative non-hypnozoite tissue stages as well, notably quiescent merozoites. Persistence of extra-vascular tissue merozoites in vivax malaria has on genetic grounds been suspected since 2011. So far, they have been parasitologically demonstrated in rodent malarial infections. There is no particular reason why they should not also occur in primate malaria of various kinds.

Problems with the Hypnozoite Theory of Relapse

July 24, 2016 - 00:12 -- Miles Markus

Speculative extrapolation from biological and genetic findings resulting from malarial research carried out in recent years, places in doubt aspects of the validity of the current concept of hypnozoite-mediated malarial relapse, entrenched though the hypothesis (usually stated by authors as a fact) is. A piece(s) of the puzzle might be missing.

Discussed in detail here

Elaborated upon further here

Malaria Elimination Dilemma

July 13, 2016 - 22:02 -- Miles Markus

A little waterbird (or was it a frog?) whispered in my ear. Aquatic organisms don’t want humans to destroy their habitats when trying to eliminate malaria. Draining of swamps, for example, would have negative consequences not only for mosquitoes but also for various other (innocent) creatures that live there. Where does this leave malariologists, so to speak? Just asking.

New paper on benefits of Ultrasound for higher yielding and purity of Artemisinin from Artemesia annua L.

June 13, 2016 - 11:48 -- Smain CHEMAT

New Method under ultrasound for rapid extraction and efficient purification of the antimalarial drug "Artemisinin" from medicinal plants.
Free download from Elsevier available till July 30th : http://authors.elsevier.com/a/1TBDt4p3AWHr29

Plasmodium vivax: Drug-induced Dormancy?

May 12, 2016 - 13:28 -- Miles Markus

Early recurrences (which are often homologous) in treated Plasmodium vivax infections are usually considered to be hypnozoite-mediated relapses. Can such recurrences sometimes or frequently be, instead, recrudescences caused by reactivation of blood stages that became temporarily quiescent following drug exposure? The experimental background to this question is given here.

Primaquine Not "Working"

May 5, 2016 - 14:02 -- Miles Markus

Therapeutic failure of primaquine in cases of Plasmodium vivax malaria is often noted by clinicians. A newly recognized, possible cause of such treatment failure is the reactivation of viable dormant parasites that might be present in one or more extra-hepatic and extra-vascular sites. Administration of primaquine will not necessarily result in these stages being killed. Here is the link to where this drug-associated matter is discussed.

Pages